Teladoc Health, Inc.
TDOCNYSEHealthcare● Active
$7.07
+$0.02(+0.21%)
Market Cap$1.3B
P/E Ratio—
52W High$9.77
52W Low$4.4
Teladoc Health, Inc. (TDOC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TDOC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Cost of Revenue | $0.77B | $0.75B | $0.76B | $0.74B | $0.65B |
| Gross Profit | $1.76B | $1.82B | $1.84B | $1.66B | $1.38B |
| Gross Margin %(computed) | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% |
| Operating Expenses | |||||
| R&D Expenses | $0.28B | $0.31B | $0.35B | $0.33B | $0.31B |
| G&A Expenses | $0.43B | $0.44B | $0.46B | $0.45B | $0.44B |
| Total Operating Expenses | $2.02B | $2.84B | $2.09B | $15.32B | $1.65B |
| Operating Income | ($0.26B) | ($1.02B) | ($0.25B) | ($13.65B) | ($0.27B) |
| Operating Margin %(computed) | -10.39% | -39.73% | -9.55% | -567.27% | -13.07% |
| Interest Income | $0.04B | $0.06B | $0.05B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.02B | $0.08B |
| Income Before Tax | ($0.24B) | ($0.99B) | ($0.22B) | ($13.66B) | ($0.38B) |
| Income Tax Expense | ($0.04B) | $0.01B | $0.00B | ($0.00B) | $0.04B |
| Net Income | ($0.20B) | ($1.00B) | ($0.22B) | ($13.66B) | ($0.43B) |
| Net Margin %(computed) | -7.92% | -38.97% | -8.47% | -567.53% | -21.09% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.14 | $-5.87 | $-1.36 | $-84.60 | $-2.73 |
| Wtd Avg Shares | 0.18B | 0.17B | 0.16B | 0.16B | 0.16B |
| EBITDA | $0.15B | $0.03B | $0.04B | ($0.01B) | ($0.03B) |
| EBITDA Margin %(computed) | 5.82% | 1.23% | 1.68% | -0.31% | -1.55% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Teladoc Health, Inc. data
About Teladoc Health, Inc. (TDOC) Income Statement
Teladoc Health, Inc. (TDOC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TDOC reported revenue of $2.53B, gross profit of $1.76B (gross margin 69.50%), and net income of ($0.20B) — a net profit margin of -7.92%.
Frequently asked questions
TDOC · 4 questionsTeladoc Health, Inc. (TDOC) reported revenue of $2.53B for 2025, down 1.5% year-over-year.
TDOC revenueTDOC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08